Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Majamaa

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Neurology|June 1, 1995
Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNAH Rusanen, K Majamaa, U Tolonen, et al.
The British Journal of Dermatology|May 8, 1999
Increased prevalence of vitiligo, but no evidence of premature ageing, in the skin of patients with bp 3243 mutation in mitochondrial DNA in the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome (MELAS)S L Karvonen, K M Haapasaari, M Kallioinen, et al.
AJNR. American Journal of Neuroradiology|January 15, 2011
Voxelwise analysis of diffusion tensor imaging and structural MR imaging in patients with the m.3243A>G mutation in mitochondrial DNAS M Virtanen, M M Lindroos, K Majamaa, et al.
Parkinsonism & Related Disorders|March 7, 2008
Parkinsonism associated with the homozygous W748S mutation in the POLG1 geneA M Remes, R Hinttala, M Kärppä, et al.
Neurology|July 28, 2004
Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathyA M Remes, S Finnilä, H Mononen, et al.
Journal of Medical Genetics|June 2, 2006
Analysis of mitochondrial DNA sequences in patients with isolated or combined oxidative phosphorylation system deficiencyR Hinttala, R Smeets, J S Moilanen, et al.
The Biochemical Journal|July 1, 1985
Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2-oxoglutarateK Majamaa, T M Turpeenniemi-Hujanen, P Latipää, et al.
Pediatrics|March 4, 2000
Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disordersJ Uusimaa, A M Remes, H Rantala, et al.
Neurology|October 23, 2002
Ubiquinone and nicotinamide treatment of patients with the 3243A-->G mtDNA mutationA M Remes, E V Liimatta, S Winqvist, et al.
Clinical and Experimental Rheumatology|April 1, 1988
Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritisK Hørslev-Petersen, K D Bentsen, P Halberg, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Neurology|June 1, 1995
Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNAH Rusanen, K Majamaa, U Tolonen, et al.
The British Journal of Dermatology|May 8, 1999
Increased prevalence of vitiligo, but no evidence of premature ageing, in the skin of patients with bp 3243 mutation in mitochondrial DNA in the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome (MELAS)S L Karvonen, K M Haapasaari, M Kallioinen, et al.
AJNR. American Journal of Neuroradiology|January 15, 2011
Voxelwise analysis of diffusion tensor imaging and structural MR imaging in patients with the m.3243A>G mutation in mitochondrial DNAS M Virtanen, M M Lindroos, K Majamaa, et al.
Parkinsonism & Related Disorders|March 7, 2008
Parkinsonism associated with the homozygous W748S mutation in the POLG1 geneA M Remes, R Hinttala, M Kärppä, et al.
Neurology|July 28, 2004
Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathyA M Remes, S Finnilä, H Mononen, et al.
Journal of Medical Genetics|June 2, 2006
Analysis of mitochondrial DNA sequences in patients with isolated or combined oxidative phosphorylation system deficiencyR Hinttala, R Smeets, J S Moilanen, et al.
The Biochemical Journal|July 1, 1985
Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2-oxoglutarateK Majamaa, T M Turpeenniemi-Hujanen, P Latipää, et al.
Pediatrics|March 4, 2000
Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disordersJ Uusimaa, A M Remes, H Rantala, et al.
Neurology|October 23, 2002
Ubiquinone and nicotinamide treatment of patients with the 3243A-->G mtDNA mutationA M Remes, E V Liimatta, S Winqvist, et al.
Clinical and Experimental Rheumatology|April 1, 1988
Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritisK Hørslev-Petersen, K D Bentsen, P Halberg, et al.
Pageof 7